DEGRADATION OF EXTRACELLULAR-MATRIX PROTEINS BY HUMAN CATHEPSIN-B FROM NORMAL AND TUMOR-TISSUES

被引:362
作者
BUCK, MR
KARUSTIS, DG
DAY, NA
HONN, KV
SLOANE, BF
机构
[1] WAYNE STATE UNIV,DEPT PHARMACOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,DEPT RADIAT ONCOL,DETROIT,MI 48201
[3] WAYNE STATE UNIV,DEPT CHEM,DETROIT,MI 48201
[4] HARPER GRACE HOSP,GERSHENSON RADIAT ONCOL,DETROIT,MI 48201
[5] GRACE HOSP,DETROIT,MI 48201
关键词
D O I
10.1042/bj2820273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our laboratory has previously demonstrated that increased malignancy of several histological types of human and animal tumours is associated with increases in their cathepsin B activity, particularly cathepsin B activity associated with plasma-membrane/endosomal vesicles or shed vesicles. Here we report that cathepsin B from normal or tumour tissues degrades purified extracellular-matrix components, type IV collagen, laminin and fibronectin, at both acid pH and neutral pH. The number and sizes of degradation products were analysed by SDS/PAGE. Cathepsin B from both sources exhibited similar activities towards, and similar patterns of cleavage of, the extracellular-matrix proteins. At neutral pH, cathepsin B from both sources appeared to undergo autodegradation, a process that was decreased in the presence of alternative substrates such as the extracellular-matrix proteins. Cathepsin B readily degraded type IV collagen at 25-degrees-C, indicating activity towards native type IV collagen. Fibronectin degradation products of 100-200 kDa and of 18 and 22 kDa were observed. A single 70 kDa fragment was released from laminin under non-reducing conditions and multiple fragments ranging from 45 to 200 kDa under reducing conditions. These results suggest that cathepsin B at or near the surface of malignant tumour cells may play a functional role in the focal dissolution of extracellular matrices.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 36 条
  • [1] L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDO(4-GUANIDINO)BUTANE (E-64) AND ITS ANALOGS AS INHIBITORS OF CYSTEINE PROTEINASES INCLUDING CATHEPSINS B, H AND L
    BARRETT, AJ
    KEMBHAVI, AA
    BROWN, MA
    KIRSCHKE, H
    KNIGHT, CG
    TAMAI, M
    HANADA, K
    [J]. BIOCHEMICAL JOURNAL, 1982, 201 (01) : 189 - 198
  • [2] THE CYSTATINS - A NEW CLASS OF PEPTIDASE INHIBITORS
    BARRETT, AJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1987, 12 (05) : 193 - 196
  • [3] BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] CATHEPSIN-B1 - LYSOSOMAL ENZYME THAT DEGRADES NATIVE COLLAGEN
    BURLEIGH, MC
    BARRETT, AJ
    LAZARUS, GS
    [J]. BIOCHEMICAL JOURNAL, 1974, 137 (02) : 387 - +
  • [6] CHELBERG MK, 1990, J CELL BIOL, V111, P262
  • [7] GOTTESMAN MM, 1990, SEMIN CANCER BIOL, V1
  • [8] MOLECULAR-CLONING OF MOUSE EPIDERMAL CYSTATIN-A AND DETECTION OF REGULATED EXPRESSION IN DIFFERENTIATION AND TUMORIGENESIS
    HAWLEYNELSON, P
    ROOP, DR
    CHENG, CK
    KRIEG, TM
    YUSPA, SH
    [J]. MOLECULAR CARCINOGENESIS, 1988, 1 (03) : 202 - 211
  • [9] KERBEL R, 1990, CANCER METASTASIS RE, V9
  • [10] ANTISENSE RNA INDUCED REDUCTION IN MURINE TIMP LEVELS CONFERS ONCOGENICITY ON SWISS 3T3-CELLS
    KHOKHA, R
    WATERHOUSE, P
    YAGEL, S
    LALA, PK
    OVERALL, CM
    NORTON, G
    DENHARDT, DT
    [J]. SCIENCE, 1989, 243 (4893) : 947 - 950